Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1,489-1,500 of 1,740
Behavioral study icon
CompletedNCT07150078

Dual Task and Attention Deficit and Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Şehitkamil
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 7 Years to 14 Years
Countries
Türkiye
Sponsor
Gaziantep Islam Science and Technology University
Condition
ADHD
Drug study icon
CompletedNCT00025779

Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 5 Years to 14 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
ADHD
Drug study icon
TerminatedEUCTR 2008-003285-26

Effect of methylphenidate formulation on ADHD-patients' adherence to medical treatment. A comparison of Medikinet retard® (ER) once daily and Medikinet® (IR) twice daily in children and adolescents...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Germany
Sponsor
Universität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie
Condition
ADHD
Drug study icon
CompletedEUCTR 2013-002720-16

EMPHAS I Evaluation of Methylphenidate (MPH) in adults with ADHD and SUD - clinical pharmacology study A Cross-sectional, Open-label, Non-randomized Single-Center Study on Adults with ADHD and ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Sweden
Sponsor
Stockholms Läns Sjukvårdsområde (SLSO)
Condition
ADHD
Drug study icon
CompletedEUCTR 2013-005017-12

Looking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Parnassia Bavo Groep - PsyQ
Condition
ADHD
Drug study icon
CompletedEUCTR 2012-000320-18

Phase shift in adult ADHD of sleep and apetite.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Parnassia Bavo Groep - PsyQ
Condition
ADHD
Biological study icon
CompletedEUCTR 2004-003853-13

Placebo controlled, randomised, double-blind, multicentre study of PlusEPA (a PUFA, Polyunsaturated Fatty Acids, supplement) as treatment for ADHD (combined type) with co-morbidity in Swedish child...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about ADHD.

ADHDBiological
Countries
Sweden
Sponsor
Hela Pharma AB
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2005-001909-25

Effekter av behandling med atomoxetine ved komorbid ADHD hos pasienter med Pervasive Developmental Disorders (Effects of treatment with atomoxetine in children with Pervasive Developmental Disorder...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Norway
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Norway
Sponsor
Condition
ADHD
Drug study icon
CompletedNCT07314333

A study to Assess How Centanafadine Interacts With Stimulants in the Body

This summary needs review. Please check the official study record and contact the research team for details.

In Salt Lake City
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Drug study icon
CompletedNCT00190957

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including El Centro
Why is this study shown?

This study is directly about ADHD.

ADHDDrugOver 18 Years
Countries
United States, Canada
Sponsor
Eli Lilly and Company
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.